Table 4.
Comparison of staged-1 clinical characteristics of SRH between the ALPPS group and PVL group.
| Variables | ALPPS (N = 6) | PVL group (N = 8) | P-value |
|---|---|---|---|
| SLLV, ml | 484.9 (396.5–568.1) |
408.3 (262.1–649.7) |
0.157 |
| Ratio of SLLV, % | 47.1 (41.0–52.5) |
40.0 (23.0–57.6) |
0.122 |
| IntraoperativeICG-R15, % | 13.4 (12.0–15.8) |
17.0 (10.4–24.1) |
0.081 |
| Laparoscopic surgery | 0 | 5 | NA |
| Operative time, minutes | 349.5 (293–408) |
164.6 (92–229) |
<0.001 |
| Blood loss, ml | 433.3 (200–600) |
185.0 (20–500) |
0.022 |
| PHLF, n (%) | 2(33.3%) | 0 | NA |
| Bile leak, n (%) | 1(16.7%) | 0 | NA |
| Failure for Stage 2, n (%) | 0 | 3(37.5%) | NA |
ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; PVL, portal vein ligation.